For the Inventor, By the Inventor

Enter assignee name

Newton, MA, United States of America

Alcresta Therapeutics, Inc.

USPTO Granted Patents = 21

% Expired Patents = 4.8

EPO Patents = 6

Trademarks = 5

Forward Citations = 11

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Robert Gallotto (16 out of 16 patents)

Bhami Shenoy (12 out of 29 patents)

Alexey L Margolin (12 out of 26 patents)

4. Eric R First (5 out of 27 patents)

5. David K Brown (5 out of 51 patents)

6. Greta L Loring (4 out of 4 patents)

7. Kenneth Gary (4 out of 16 patents)

8. Edward S Park (4 out of 4 patents)

9. Willem Robert Klaas Schoevaart (4 out of 5 patents)

10. Michiel Christian Alexander Van Vliet (4 out of 6 patents)

11. David Widom (3 out of 3 patents)

12. Albert Archie Stone (2 out of 2 patents)

13. David J Brown (1 out of 1 patent)

14. Willem Robert Klass Schoevaart (0 patent)

21 patents: Sort by Forward Citations

1. 12514839 - Enteral feeding devices and related methods of use (2026-01-06),

2. 12178785 - Methods, compositions, and devices for supplying dietary fatty acid needs (2024-12-31),

3. 12178784 - Methods, compositions, and devices for supplying dietary fatty acid needs (2024-12-31),

4. 12137713 - Devices and methods for the preparation of a nutritional formula (2024-11-12),

5. 12059391 - Methods, compositions, and devices for supplying dietary fatty acid needs (2024-08-13),

6. 11998511 - Methods, compositions, and devices for supplying dietary fatty acid needs (2024-06-04),

7. 11944596 - Enteral feeding devices and related methods of use (2024-04-02),

8. 11872191 - Methods, compositions, and devices for supplying dietary fatty acid needs (2024-01-16),

9. 11478431 - Ingestible medical delivery devices (2022-10-25),

10. 11291236 - Devices and methods for the preparation of a nutritional formula (2022-04-05),

11. 11045440 - Enteral feeding devices and related methods of use (2021-06-29),

12. 11045396 - Devices and methods for the supplementation of a nutritional formula (2021-06-29),

13. 10987280 - Methods, compositions, and devices for supplying dietary fatty acid needs (2021-04-27),

14. 10828239 - Methods, compositions, and devices for supplying dietary fatty acid needs (2020-11-10),

15. 10716761 - Ingestible medical delivery devices (2020-07-21),

Company Overview

Alcresta Therapeutics, Inc. is a biotechnology company based in Newton, MA, focused on developing innovative solutions for patients with complex nutritional needs. The company specializes in enzyme-based therapies aimed at improving the absorption of nutrients in patients with gastrointestinal disorders. Alcresta's research emphasizes the intersection of biochemistry and clinical nutrition, striving to enhance patient outcomes through advanced therapeutic approaches tailored to individual dietary requirements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

21 Patents

#16 in Newton, MA

#945 in Massachusetts

#15,695 in US

#29,961 in the World

Newton, MA, United States of America

Alcresta Therapeutics, Inc.

Forward Citations = 11

13 inventors:

Robert Gallotto (16 out of 16 patents)

Bhami Shenoy (12 out of 29 patents)

Alexey L Margolin (12 out of 26 patents)

4. Eric R First (5 out of 27 patents)

5. David K Brown (5 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alcresta Therapeutics, Inc.. Retrieved from https://idiyas.com/company/alcresta-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…